Company Filing History:
Years Active: 2013-2016
Title: Pei Zhang: Innovator in Hepatitis C Research
Introduction
Pei Zhang is a notable inventor based in Rockville, MD (US), recognized for his contributions to the field of hepatitis C research. With a focus on developing neutralizing antibodies, his work aims to combat the hepatitis C virus effectively. He holds 2 patents that reflect his innovative approach to addressing this significant health issue.
Latest Patents
Zhang's latest patents include groundbreaking inventions related to hepatitis C virus neutralization. One patent discloses a specific epitope on the surface of the hepatitis C virus that induces a neutralizing antibody response in vivo. The neutralizing monoclonal antibodies that bind specifically to this epitope are designed to block the virus from infecting cells. Another patent focuses on compositions that induce and improve an immune response to hepatitis C virus (HCV). This invention provides methods for making and using compositions that include epitopes of the HCV E2 structural protein, which are involved in promoting or inhibiting the neutralization of HCV.
Career Highlights
Pei Zhang is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to contribute significantly to the understanding and treatment of hepatitis C. His research is vital in the ongoing battle against this virus, which affects millions worldwide.
Collaborations
Zhang collaborates with esteemed colleagues, including Marian Elaine Major and Stephen M Feinstone. These partnerships enhance the research efforts and broaden the impact of their findings in the scientific community.
Conclusion
Pei Zhang's innovative work in hepatitis C research exemplifies the critical role of inventors in advancing medical science. His patents and collaborations contribute to the ongoing fight against viral infections, showcasing the importance of innovation in healthcare.